The program opened with "To rito " from Transparencias (7 997) by Eduardo

Gamboa, performed by University of Iowa School o f Music faculty members Tadeu Coelho (flute) and Ksenia Nosikova (piano), followed by President M a ry Sue
Coleman's introduction of the speaker.
First, I would like to thank Professors Coelho and Nosikova fo r the beautiful introductory. Next, it is imperative to thank President Coleman and the se lection committee for this very particular and great honor. W h ile it is a particular honor, it is not, of course, singular, and I hope over the course of this presentation to identify many of the people whose collaboration and collegiality have enabled me to be in the position of delivering this talk to all of you today. A s you know, the title is "Genes and Environment, Science and Society," and what I hope to outline for you is both the scientific basis for the w ork that we do and our accomplishments so far, as well as the broader implications for society of not just our w ork but of studies of genes and environment in general.
The mandate for these talks was outlined by President Freedman in 1 9 8 3 :
To present significant aspects of his or her scholarly w ork to the entire university community and thereby stimulate intellectual communication among the many disciplines that comprise the university.
M y motive in speaking to you today is best captured by Jacob Bronowski in his 1 9 5 6 book, Science and Human Values. Dr. Bronowski characterized the w o rk of a scientist as follows: "W h a t a scientist does is compounded of two interests: the interest of his time, and his own interest." Th is does, in deed, well capture what I w ill outline today.
A s a final introductory comment, let me state for those of you in the audi ence, and I hope there are some, at the beginning of your careers, whether in high school, college, graduate school, o r even early in your professional careers, I hope that if nothing else, you can realize from what I outline here that for me, as well as for you, it is a great privilege to live in this country and in this time. W ith hard w ork, intelligence and some luck, it is possible to not only w o rk on what interests you, the kinds of things that drive you to stay up late into the evening, reading and thinking about problems, about ques tions, to establish close personal friendships with individuals who share a sim ila r passion, but also to have that w ork be something of value to science as a whole. W h ile few of us can w o rk on the most important questions of the time and while most certainly my own w o rk is unexceptional in comparison to the important problems facing us as a human society today, it does pro vide for the opportunity to make incremental improvements in the lives of people everywhere. No matter what your chosen field, if you can both enjoy yo ur w o rk and feel satisfaction that lives of people somewhere have been bettered by the w o rk that you've done, whether through the w ork itself or even through your personal contact with your fellows, you can consider your life w ork to be a success.
I w ill outline three scientific opportunities that have resulted from our work. F irst, I w ill describe our w o rk on the Human Genome Project, an extensive collaborative effort that involved many individuals here at the University, as well as around the world.
Next, I w ill talk about how we have applied some of these developments to our own specific interests in diseases that cause birth defects. I w ill de scribe our successful identification of a particular gene that causes inherited eye and tooth abnormalities, our ongoing w ork to better understand how cleft lip and palate, a common birth defect, results from a combination of gene and environmental influences, and finally, how we have been able to extend these studies from outside of Iowa to international populations where the w o rk itself has both greater urgency and opportunity.
Lastly, I w ill try to synthesize how these particular projects and the broader ones they represent raise issues of morals, ethics and values for all of us. Th is world is given to us on loan. We come and we go; and after awhile we leave earth and a ir and water to others who come after us. M y generation, or perhaps the one preceding mine, has been the first to engage, under the leadership of the exact sciences, in a destructive colonial warfare against nature. The future w ill curse us for it.
These two quotations capture both the enthusiasm, excitement and prom ise of the genome project as outlined by Watson and Crick and the concerns of many about the potential for terrible effects and outcomes that might also result from this work.
The genome project itself has as its very core the promise of delivering gene therapy o r the treatment of genetic d isorders with magic genetic bul lets that could potentially correct even the most serious birth defects o r d iso r ders of aging, such as A lzhe im e r's disease, Parkinson's, cardiovascular disease, diabetes and many others. It also holds out the promise of cloning, whether that be individual organs fo r replacement parts in humans o r an entire individual from a single cell, as occurred with the sheep, Dolly.
The reality of the Human Genome Project is different, and at the present time, affords us improvements in diagnostic capability, particularly the a b il ity to identify a predisposition to a d iso rd e r such as breast cancer o r Alzheim er's disease before it begins to manifest itself clinically. In addition, the genome project is delivering tremendous advances in technology, par ticularly in biology, as it is often only through gene identification and discov e ry that the involvement of pharm acologists, biochemists, anatomists, embryologists, physiologists and others can begin to determine the best mechanism by which treatment and prevention can be undertaken.
Genome-the genetic component o f an individual or species
I've yet to define genome, and it is necessary to do so, for the word itself can be used in at least two important ways. F irst, the human species, as is true of all species, has its own genome: that is, the invariant nature of the D N A sequence which contains the information necessary for making and constructing from a fertilized egg an individual of that particular species. At the same time, each of us, unless an identical twin, differs from one another, and many of those differences result not just from changes in the environ ment in which one grows up, but rather from the very underlying nature of the genetic material itself and how it can vary from person to person. These variations include common differences, such as those found in skin, hair or eye color, as well as the rare differences which may underlie a predisposi tion to a particular disorder.
Identical twins, by virtue of the fact that they appear to be exact copies of one another, tell us that our physical appearance and structure is almost, if not entirely, genetically determined-a bold statement, but one that cer tainly can be supported by looking at two individuals who share all of their genetic material in common. O f course, it is equally true that even identical twins do not share a large number of personality traits, interests, abilities or even acquired diseases of childhood and adulthood, so it is important to always recall in the context of any talk on the genome that environment plays a critical and essential component, as well.
Human Genome Perspective
Scientists have known since the m id -1 9 5 0 's that we have 2 3 pairs of chromosomes inherited in equal numbers from our mothers and our fathers. In the last few months, the federally funded efforts exceeded one billion of the three billion letters necessary to be defined. In just the last few weeks, the company Celera, headed by Craig Venter, has reported that it now has in hand 9 0 % of all of the sequence of the human genome. Th e ir group has taken a strategy which has resulted in the sequence being accumulated in short bits o r stretches, and although these have yet to be assembled into a long, continuous read as one would find necessary to make any sense of a chapter o r an entire book, the effort, if confirmed, is impressive and holds out the promise for a substantial portion of all the sequence being truly in hand sometime in the year 2 0 0 0 .
Identifying a single base pair change that might underlie a human d iso r der once the sequence is in hand w ill still be equivalent to identifying a single individual on the planet as if arriving on earth from outer space. For many years, scientists have used a variety of maps, in particular genetic and physical maps, to locate the positions of genes and mutations, and it was through this effort that our laboratory first began its extensive involve ment with the Human Genome Project. An example of the importance of these kinds of efforts is reflected in the talk that Michael W elsh gave in this forum just a few years ago in describing his own w o rk on the cystic fib ro sis Th is project was successful because of the interactive and complementary efforts of the investigators and the many graduate students, postdoctoral fellows and technicians who took part in it because of the support of the N IH . It also afforded our group the ability to now extend our interests in genetic mapping into the application of these maps to better understand birth defects, which had been from the beginning our p rim a ry interest.
Identification of the Gene for Rieger Syndrome
The application of these powerful new techniques had, in our own lab, its first specific success when in 1 9 9 6 Elena Semina, a postdoctoral fellow, identified a previously unknown human gene that causes an inherited d iso r der comprised of glaucoma and dental abnormalities. T h is disorder, the Rieger syndrome, was first form ally described by Herw ig Rieger in 1 9 3 5 .
He was an Austrian ophthalmologist who recognized that families in which dominant inheritance is observed had individuals who were affected with both glaucoma and dental abnormalities. W h ile the disorder is extremely rare, we felt that it could serve as a model for other forms of glaucoma and dental anomalies, and so in the late 19 8 0 's, we attempted to identify the causal gene.
W e were assisted in this first by the w ork of graduate students in the laboratory who showed that chromosomal deletions in a particular area on human chromosome 4 were associated with this syndrome, and in 199 2 , when we were able to demonstrate conclusively that a gene for Rieger syn drome was located in the mid-portion of the long arm of human chromo some 4 (M urray et al., 1 99 2 ). Subsequently, Dr. Semina and other w orkers in our lab set out to find the specific nature of the gene and the causal mutations in it that might lead to these disorders. W e were able to make use of the technologies of the Human Genome Project in both narrowing the location in which the gene might be found, and eventually in identifying its very specific nature.
In 1 9 9 6 (Semina et al.), we were fortunate to be the first laboratory on our campus to identify a previously unknown gene that was causal in a human genetic disorder, and indeed, the first gene in which glaucoma was an important phenotype. Th is w ork was only successful through the collabo rative interactions of many clinicians such as Lee Alward here on our own campus, as well as other clinicians and other scientific investigators off cam pus who assisted us in developing the tools and reagents to find the gene.
The gene itself was of substantial interest, because it was a member of a class of very ancient genes, called "homeobox genes," which had been shown only a decade before to play an important role in the determination of the body plan. These genes are present and conserved in almost all com plex organism s and have been particularly well characterized in the fruit fly. O u r gene was a member of a particular class of fruit fly genes in which abnormalities can result in body plan duplications, such as fruit flies that have two sets of w ings, rather than the normal single set. Identification of this gene and its gene structure allowed Dr. Semina to characterize muta tions that cause the condition and have now allowed us to extend these studies to collaborations with individuals such as D rs. Andy Russo, Roger W illia m so n and Baoli Yang on campus to better study the protein and to establish a mouse model for the disorder which w ill enable us, we hope, to eventually move on to mechanisms for treating disorders of craniofacial structures.
W h ile I have summarized this w ork relatively quickly, it is important to recognize that it took us almost a decade to find this gene and that the w ork itself involved many people and many years of effort. W e are particularly heartened by the fact that with the advances in the Human Genome Project outlined previously in this talk, a project such as this if now undertaken in the lab could likely be completed by a graduate student w orking alone in a year or two, enabling such students to spend the latter part of their graduate careers in understanding the functionality and clinical importance of such a disorder. In only ten years, then, we have moved from a project such as this, requiring hundreds of persons many years, as was necessary in the discov ery of the cystic fib ro sis o r muscular dystrophy genes, to projects that could almost be completed by undergraduate students in a summer rotation. Th is then affords tremendous opportunities for the identification of other kinds of genes, ones that have broad implications on human health in the future. O u r group has chosen to study these disorders and to try and identify the causes, both genetic and environmental. Previous w ork by our group and many others has demonstrated that important genetic components can in clude major chromosome anomalies, such as an extra chromosome number 13, many single gene o r dominant o r recessive conditions, and finally, that a common cause is likely to be the interactive effect of more than one gene at a time.
Environmental causes are also common and reflect the need fo r adequate nutrition with both vitamin A and folic acid deficiency being associated with birth defects. Exposures to environmental teratogens that can include com mon exposures such as cigarette smoke o r alcohol, as well as more unusual exposures such as to a commonly used anticonvulsant drug, Phenytoin, can also result in a child being born with a cleft of the lip o r palate.
Beginning in the 19 8 0 's, our lab has been extensively involved in trying to better understand how these defects arise, with an initial emphasis on a study of genetic factors. To carry out these studies, we identify candidate genes. These are genes which are chosen because they are expressed in the tissues of the developing face o r palate o r because defects of these genes in animal models such as the mouse can result in clefts of the lip o r palate.
Once a gene is identified, our laboratory would undertake an extensive molecular characterization, often requiring the w o rk of one o r two techni cians and graduate students o r postdocs for one o r two years, before we would even have in hand the necessary information to carry out our genetic studies on the families. W hen this molecular characterization was completed, mutation detection o r searching for the defects in the gene, in tens, hun dreds o r even thousands of individuals could be undertaken. The advances in the genome project, particularly the sequence that is already appearing in our hands and on computer screens even as we speak, has now greatly minimized the characterization step of this project so that we can move directly from selection to mutation detection, taking years off a project and allowing us to study not just one o r two candidate genes but tens, o r even hundreds. In an accumulation of w ork performed in our laboratory over the last decade and a half, beginning with H o lly A rd ing e r and culminating with the w ork of Andrew Lidral in the last few years, we've identified several genes, two of which are shown in the figures below. One is the M SX1 homeobox gene, a gene important in developmental regulation, which shows important statistical association with cleft lip and palate in humans. Th is finding is validated by the fact that mutations in this gene in the mouse result in clefts in the mouse, and the gene is expressed in the critical tissues of facial expression.
Sim ila rly, a growth factor gene, called transform ing growth factor beta 3, also has a strong statistical association with cleft lip and palate in humans, and sim ila rly, inactivation of this gene in the mouse results in a cleft condi tion, and its expression is also found in that same area. I've been fortunate enough to travel almost yearly to the Philippines to carry out these studies. O u r w o rk in the Philippines has been characterized very sim ila rly to our w o rk here in that the sp irit of cooperation and collaboration has allowed us to progress rapidly toward important findings which we hope w ill set the stage for prevention and intervention tria ls to begin soon.
The Philippines is a classic tropical island often described as a paradise, but in fact, the majority of the population lives in extremely indigent and de prived conditions. O u r strategy there has been to partner with the volunteer organization Operation Sm ile, and local non-governmental organizations, such as the Health O rganization for the Poor Enterprise (H.O .P.E.) Founda tion, to w ork with local hospitals, authorities, public health officials and the federal and provincial government so that we can bring together groups of experts who have a good understanding of the people and their needs that allow us to move forward on these projects. W e've been able to establish a set of field w orkers supervised by Sandy Daack-Hirsch. After our yearly m issions to the Philippines, they continue to collect information as well as sight, and one that never fa ils to move even those of us who have seen it many times before. The human tragedy of this d isorder is brought home time and again by the stories the fam ilies and children tell us of how they have been ostracized, sick and unable to identify funds to have an opera tion performed which in the United States would never be denied to even the poorest of children. Many of the children we see are clearly beautiful, both inside and on the outside, and the fact that they are unfairly denied these treatments is difficult to understand, particularly when we return home to a land in which we are surrounded by so much wealth and abundance.
To initiate our studies there, we have performed epidemiologic as well as genetic and environmental studies. W e have established recurrence risk data and also incidence data which has been collected in a number of hospitals in the Philippines in collaboration with their own investigators. The collec tion of blood samples has allowed us to carry out genetic studies sim ila r to those that we carried out in Iowa. lation, despite the fact that we have actually been able to study hundreds of more affected cases there, giving us much greater power for detection than was possible through the studies in Iowa where the population is much smaller and the rate of clefting much lower. These findings suggested to us that environmental components might be even more important in the Philippines than they are in Iowa, and that we could then identify these by looking for them specifically. is pointing out some of the challenges raised by the genome project and our technological abilities to undertake such studies and offering suggestions for how we might think about these things in the future.
CL/P Incidence by Socioeconomic Status (SES)
Philippine Candidate Gene Studies
The genome project is providing a future in which we can better under stand complex diseases, better diagnose them and better undertake gene discovery processes. At the same time, our ability to do this raises important social and ethical issues, both in our own country and overseas. A t home, we are challenged by concerns over genetic discrim ination, and whether individuals who are identified as having traits that predispose them to ge netic diseases may in fact be discriminated against by insurance compa nies, employers o r schools who w ill find them too high ris k to take under their wing as they might do with le ss-a t-risk citizens. These are very real concerns, and as the genome project improves in its ability to carry out such diagnoses from vanishingly small amounts of D N A , we have the possibility that dozens o r even hundreds of such tests could be performed at a price low enough to be affordable by many Americans, yet provide them with information that once in hand they find they don't really want. W h ile it is important to always maintain the perspective that knowledge of such d iso r ders can often be power, we have to realize that this power can be doubleedged. On one side, it w ill allow affected individuals to undertake preventive measures through early physical screening o r even adopt preventative strat egies that can lower their ris k for developing cancer, high blood pressure, o r diabetes; on the other side, the discrim inatory factor must always been considered and thought about.
Sim ila rly , the ability to identify such individuals with high resolution has also brought about concerns about identity in general. W e have all read the popular press accounts of genetic identity surrounding popular athletic and political figures, such as O . J. Sim pson, B ill Clinton, and even the long-dead Thomas Jefferson, who have had their personal lives held up to intense public, as well as sometimes legal, scrutiny. W h ile in many cases, the pur pose of these is to catch and convict "bad g uys," the same technologies are also potentially subject to great abuses and invasion of personal privacy, and the balance between these is yet to be adequately identified o r achieved in our society.
At the international level, many of these same concerns continue. How such information is going to be used for the world as a whole and whether genome projects w ill freely identify D N A sequence in a way that can benefit all of mankind and not just a few small, very wealthy private interests are examples of issues yet to be resolved. There are ongoing concerns about patenting and licensing issues related to human genetic material, and every week one can collect numerous examples from the popular literature that reflect o r refer to these fears of Americans and others. A s noted above, the genome project has the potential for solving many of the w orld's problems, and genome projects that involve agricultural products such as wheat, corn, soybeans, as well as animal products such as the pig and the cow, all hold great promise for improving the availability of the world's food supply. None theless, as all of you are aware from reading the paper, grave concerns, particularly in areas outside the United States about the safety of genetically modified organism s, have become rampant in the last couple of years and are already leading to proscriptions on products that have wide markets already established in the United States.
A recent article in Science described rice which has been modified to contain and express the genes for vitamin A. If you live in an underdevel oped country, vitamin A deficiency is not only endemic but is a significant cause of morbidity and mortality, particularly in the young and in pregnant women. The ability to have the vitamins delivered through a point source such as rice, which is already widely accepted as a food source, would seem a miracle. Th is seeming miracle, however, has to be counterbalanced and brought to resolution with the concerns about the safety of doing such genetic modification and whether in the long run these modifications might, indeed, cause more harm than good.
W h ile I'm neither an expert on genetically modified organism s, nor do I have the time to discuss them in great detail, it is clear from any reading of the popular press that this is a major concern, not only in an agricultural state such as Iowa, but for countries all around the w orld, both highly devel oped and underdeveloped. W e need to better understand through educa tion how genetic modification can w ork, when it can be dangerous and when it can be beneficial, and how to balance these in some way.
Finally, in our own w ork, concerns about human genetic modification also come to the fore, and at any time that we discuss identifying causes of cleft lip and palate, as an example, we are also really discussing what might happen if we could at some time in the future, in some way, genetically cure o r prevent this. How we as a human race w ill resolve this need to maintain our individuality and our individual freedoms, with the desire to prevent the tragic occurrence of both physical and mental abnormalities in our children,
has also yet to be resolved.
The genome project holds out tremendous promise, and our own small amount of w ork in looking into the development of these genetic resources and then applying them to studies of gene-environment interactions has only highlighted to myself, and I hope to all of you even more, that at the same time we push and make progress with our scientific advances, we need to constantly thinking and evaluating how they are going to have an impact on our society and on the many different societies around the world.
In closing, I'd like to thank a number of people for getting me to the point that I'm at today in being afforded the tremendous honor of being allowed to speak in front of this community and university group. Although there are many, many people to whom I owe a tremendous debt of gratitude, includ ing the scientists I've tried to mention in the course of my talk, there are a few other people I would like to highlight. F irst would be Jim Hanson, who first hired me here at the U nive rsity of Iowa and gave me the resources and the empowerment to begin and carry out my research studies. He himself was brought here by Dr. Hans Zellweger, whose tragic suicide in the late 1 9 8 0 's made me realize that even the most wonderful person, b rillia nt and outstanding clinician, can have troubles that may seem too insurmountable to overcome. Hugh M o rris, who is here today in the audience, was the first person at the University to be nice to me when he didn't have to be, and I'll always be grateful to him for taking a young, naïve Assistant Professor under his wing and showing me the way to de velop into not only a scientist, but I hope, a person. It was through Hugh that met Michael So lu rsh , the consummate developmental biologist, father and husband, whose untimely death just over five years ago was the single greatest blow to my personal and professional career. I w ill never get over the loss of Michael's friendship and his abilities, nor w ill our university recover from the loss of this gifted academician. W e can, however, take some solace in the fact that his wonderful daughter, Libby, is carrying on the tradition of kind ness and generosity that Michael showed to me. Lastly, and most impor 
